Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
|
|
Integrated Regional Information Networks - June 14, 2002
The money has been pledged over two years, with $3.3 million for the first year.
Asked whether there were plans to reduce market prices of the drugs, the director-general of the Centrale d'Achat des M dicaments Essentiels au Rwanda, Ernest Rwagasana, said people should not expect instant reduction, but, if all went well, Rwandans could expect the drugs at cheap prices, RNA reported.
Meanwhile, a meeting of the African Association of Purchasing Centres for the Essential Generic Drugs, held in Kigali last week, recommended that medical and pharmaceutical companies should never again go beyond a profit of 5 percent on HIV/AIDS drugs in Rwanda, RNA reported.
020614
IR020609
Copyright © 2002 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980 – 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .